Best Inflammatory Markers for Clinical Practice
C-reactive protein (CRP) is the single best inflammatory marker for routine clinical use, having superior analyte and assay characteristics compared to all other available inflammatory markers. 1
Why CRP is Superior
The CDC/AHA guidelines definitively establish CRP as the optimal inflammatory marker based on comprehensive laboratory evaluation 1:
- Assay standardization: CRP has proficiency testing programs through the College of American Pathologists and standardization programs at the CDC, unlike other markers 1
- Analyte stability: CRP remains stable in serum/plasma without requiring immediate processing or freezing to -70°C (unlike cytokines) 1
- Commercial availability: Widely available high-sensitivity CRP (hs-CRP) assays with acceptable precision down to 0.3 mg/L 1
- Acceptable precision: Coefficient of variation is consistently acceptable across platforms 1
Practical CRP Measurement Protocol
When ordering CRP for inflammatory assessment 1:
- Obtain 2 measurements (fasting or nonfasting) optimally 2 weeks apart and average the results
- If CRP >10 mg/L: Repeat the test and evaluate for acute infection or inflammation
- Report results in mg/L to 1 decimal point only
Risk Stratification Using CRP
Use these specific cutoffs for cardiovascular and inflammatory risk assessment 1:
- Low risk: <1.0 mg/L
- Average risk: 1.0-3.0 mg/L
- High risk: >3.0 mg/L
Other Inflammatory Markers: Why They Are Inferior
Erythrocyte Sedimentation Rate (ESR)
- Limited utility: Longer half-life makes it better for chronic conditions but less useful for acute assessment 2
- Better for monitoring: More appropriate for tracking chronic inflammatory diseases rather than diagnosis 2, 3
- Use alongside CRP: ESR and CRP together provide complementary information, with CRP superior for acute conditions 1, 4
Cytokines (IL-6, TNF-α, IL-1, IL-8, IL-10, IL-18)
- Research tools only: Require immediate processing and freezing to -70°C 1
- Short half-life: Some cytokines like IL-1 degrade rapidly 1
- Standardization problems: Different antibody pairs prevent comparable results between assays 1
- Cannot quantify normal ranges: Most assays designed for acute inflammation cannot measure low concentrations in healthy individuals 1
Soluble Adhesion Molecules (sICAM-1, sVCAM-1, E-selectin, P-selectin)
- Not ready for clinical use: Precluded from routine laboratory use for same reasons as cytokines 1
Fibrinogen
- Stability issues: Unstable unless analyzed immediately with clotting assays 1
- Standardization problems: WHO standard exists only for mass assays, not the commonly used functional assays 1
- Variable methodology: Different measurement methods (immunoassay vs. functional) complicate interpretation 1
Serum Amyloid A (SAA)
- Limited clinical validation: Less extensively studied than CRP for clinical decision-making 1
- No clear advantage: Does not outperform CRP in predictive ability 1
Clinical Context: When to Use Which Marker
For acute inflammatory assessment in emergency settings 1:
- CRP is mandatory
- ESR provides complementary information
- Full blood count with differential
- Fecal calprotectin when inflammatory bowel disease is suspected
For chronic inflammatory monitoring 2, 3:
- ESR may be more appropriate due to longer half-life
- CRP for assessing treatment response
Important Caveats
CRP elevation occurs in multiple conditions beyond infection 1:
- Inflammatory bowel disease
- Rheumatoid arthritis
- Long-term alcoholism
- Any acute inflammatory process
Neither ESR nor CRP are specific 3, 5:
- Must be interpreted with clinical history and physical examination
- Not all systemic rheumatic diseases show elevation 5
- Discordance between ESR and CRP is common in chronic inflammatory conditions 3
IL-6 and CRP have non-inflammatory roles 6:
- Both participate in somatic maintenance beyond inflammation
- Elevated levels may reflect tissue repair or pathogen tolerance, not just inflammation